Anaplastic large cell lymphoma screening: Difference between revisions
Jump to navigation
Jump to search
(Category) |
Kamal Akbar (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for Anaplastic large cell lymphoma | |||
==Screening== | ==Screening== | ||
*There is insufficient evidence to recommend routine screening for Anaplastic large cell lymphoma | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Latest revision as of 17:04, 20 December 2018
Anaplastic large cell lymphoma Microchapters |
Differentiating Anaplastic large cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Anaplastic large cell lymphoma screening On the Web |
American Roentgen Ray Society Images of Anaplastic large cell lymphoma screening |
Directions to Hospitals Treating Anaplastic large cell lymphoma |
Risk calculators and risk factors for Anaplastic large cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
There is insufficient evidence to recommend routine screening for Anaplastic large cell lymphoma
Screening
- There is insufficient evidence to recommend routine screening for Anaplastic large cell lymphoma